GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Quick Ratio

Cleo Diagnostics (ASX:COV) Quick Ratio : 51.61 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Cleo Diagnostics's quick ratio for the quarter that ended in Dec. 2023 was 51.61.

Cleo Diagnostics has a quick ratio of 51.61. It generally indicates good short-term financial strength.

The historical rank and industry rank for Cleo Diagnostics's Quick Ratio or its related term are showing as below:

ASX:COV' s Quick Ratio Range Over the Past 10 Years
Min: 0.29   Med: 0.5   Max: 51.61
Current: 51.61

During the past 1 years, Cleo Diagnostics's highest Quick Ratio was 51.61. The lowest was 0.29. And the median was 0.50.

ASX:COV's Quick Ratio is ranked better than
99.65% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 2.055 vs ASX:COV: 51.61

Cleo Diagnostics Quick Ratio Historical Data

The historical data trend for Cleo Diagnostics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Quick Ratio Chart

Cleo Diagnostics Annual Data
Trend Jun23
Quick Ratio
0.29

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
Quick Ratio 0.50 0.29 51.61

Competitive Comparison of Cleo Diagnostics's Quick Ratio

For the Medical Devices subindustry, Cleo Diagnostics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleo Diagnostics's Quick Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Quick Ratio falls into.



Cleo Diagnostics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Cleo Diagnostics's Quick Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Quick Ratio (A: Jun. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.58-0)/2.02
=0.29

Cleo Diagnostics's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(10.27-0)/0.199
=51.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleo Diagnostics  (ASX:COV) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Cleo Diagnostics Quick Ratio Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleo Diagnostics (ASX:COV) Business Description

Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines